Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitalists | 28 | 2023 | 131 | 6.610 |
Why?
|
Hospitalization | 48 | 2023 | 849 | 6.360 |
Why?
|
Inpatients | 31 | 2023 | 297 | 5.510 |
Why?
|
Anemia | 6 | 2023 | 128 | 3.660 |
Why?
|
Cost-Benefit Analysis | 35 | 2019 | 454 | 3.650 |
Why?
|
Physician-Patient Relations | 23 | 2023 | 610 | 3.200 |
Why?
|
Quality of Health Care | 20 | 2022 | 380 | 3.080 |
Why?
|
Medication Adherence | 6 | 2023 | 129 | 3.020 |
Why?
|
Internal Medicine | 17 | 2017 | 347 | 2.960 |
Why?
|
Humans | 295 | 2023 | 86643 | 2.720 |
Why?
|
Patient Satisfaction | 16 | 2020 | 455 | 2.630 |
Why?
|
Decision Making | 15 | 2020 | 642 | 2.600 |
Why?
|
Patient-Centered Care | 15 | 2023 | 203 | 2.590 |
Why?
|
Continuity of Patient Care | 13 | 2020 | 169 | 2.560 |
Why?
|
Fatigue | 6 | 2022 | 174 | 2.520 |
Why?
|
Internship and Residency | 24 | 2023 | 1004 | 2.460 |
Why?
|
Medicare | 13 | 2023 | 410 | 2.440 |
Why?
|
Health Care Costs | 16 | 2019 | 238 | 2.400 |
Why?
|
United States | 81 | 2023 | 6672 | 2.400 |
Why?
|
Health Status | 13 | 2020 | 360 | 2.340 |
Why?
|
Health Services Research | 14 | 2015 | 136 | 2.310 |
Why?
|
Aged | 110 | 2023 | 18415 | 2.290 |
Why?
|
Patient Discharge | 11 | 2020 | 300 | 2.270 |
Why?
|
Male | 163 | 2023 | 40965 | 2.260 |
Why?
|
Erythrocyte Transfusion | 4 | 2023 | 60 | 2.240 |
Why?
|
Patient Preference | 6 | 2020 | 105 | 2.120 |
Why?
|
Length of Stay | 19 | 2018 | 702 | 2.110 |
Why?
|
Communication | 18 | 2019 | 441 | 2.070 |
Why?
|
Female | 157 | 2023 | 44532 | 2.010 |
Why?
|
Middle Aged | 113 | 2023 | 25028 | 1.990 |
Why?
|
Pressure Ulcer | 5 | 2018 | 42 | 1.950 |
Why?
|
Comparative Effectiveness Research | 8 | 2014 | 53 | 1.870 |
Why?
|
Personnel Staffing and Scheduling | 7 | 2020 | 93 | 1.750 |
Why?
|
Pharmacogenetics | 12 | 2022 | 434 | 1.690 |
Why?
|
Pneumonia | 5 | 2022 | 179 | 1.620 |
Why?
|
Vitamin D Deficiency | 3 | 2022 | 103 | 1.620 |
Why?
|
Quality-Adjusted Life Years | 22 | 2018 | 138 | 1.620 |
Why?
|
Quality Indicators, Health Care | 6 | 2017 | 144 | 1.590 |
Why?
|
Chicago | 37 | 2022 | 1379 | 1.580 |
Why?
|
Drug Costs | 4 | 2022 | 62 | 1.570 |
Why?
|
Health Policy | 12 | 2020 | 180 | 1.510 |
Why?
|
Patient Participation | 8 | 2021 | 216 | 1.440 |
Why?
|
Efficiency, Organizational | 5 | 2019 | 58 | 1.430 |
Why?
|
Costs and Cost Analysis | 6 | 2018 | 153 | 1.420 |
Why?
|
Cost of Illness | 11 | 2018 | 150 | 1.410 |
Why?
|
Vitamin D | 4 | 2023 | 261 | 1.390 |
Why?
|
Practice Patterns, Physicians' | 13 | 2019 | 582 | 1.380 |
Why?
|
Adult | 79 | 2023 | 25648 | 1.320 |
Why?
|
Community-Acquired Infections | 5 | 2022 | 63 | 1.320 |
Why?
|
Hospital Costs | 8 | 2018 | 105 | 1.310 |
Why?
|
Health Expenditures | 7 | 2011 | 86 | 1.300 |
Why?
|
Gastrointestinal Hemorrhage | 5 | 2017 | 229 | 1.290 |
Why?
|
Patient Care Team | 7 | 2016 | 280 | 1.290 |
Why?
|
Health Priorities | 5 | 2014 | 23 | 1.280 |
Why?
|
Safety Management | 5 | 2013 | 56 | 1.260 |
Why?
|
Delivery of Health Care | 7 | 2021 | 426 | 1.240 |
Why?
|
Medical Staff, Hospital | 10 | 2017 | 107 | 1.220 |
Why?
|
Quality of Life | 14 | 2018 | 1585 | 1.210 |
Why?
|
Prostatic Neoplasms | 11 | 2011 | 1721 | 1.180 |
Why?
|
Academic Medical Centers | 15 | 2019 | 379 | 1.150 |
Why?
|
Surveys and Questionnaires | 28 | 2021 | 2501 | 1.140 |
Why?
|
Aged, 80 and over | 40 | 2020 | 6509 | 1.140 |
Why?
|
Physicians, Primary Care | 6 | 2021 | 104 | 1.120 |
Why?
|
Geriatrics | 4 | 2015 | 61 | 1.120 |
Why?
|
Health Care Reform | 4 | 2020 | 90 | 1.110 |
Why?
|
Urology | 3 | 2023 | 110 | 1.110 |
Why?
|
Hospitals | 9 | 2022 | 294 | 1.100 |
Why?
|
Primary Health Care | 7 | 2020 | 339 | 1.100 |
Why?
|
Attitude of Health Personnel | 10 | 2019 | 636 | 1.090 |
Why?
|
Socioeconomic Factors | 16 | 2019 | 567 | 1.080 |
Why?
|
Decision Support Techniques | 8 | 2018 | 160 | 1.060 |
Why?
|
Hospitals, Teaching | 10 | 2015 | 115 | 1.060 |
Why?
|
Sleep | 9 | 2019 | 444 | 1.060 |
Why?
|
Risk Assessment | 18 | 2021 | 2261 | 1.050 |
Why?
|
Quality Assurance, Health Care | 6 | 2010 | 220 | 1.050 |
Why?
|
Patient Handoff | 2 | 2017 | 93 | 1.050 |
Why?
|
Logistic Models | 15 | 2023 | 1186 | 1.050 |
Why?
|
Physicians | 9 | 2023 | 673 | 1.040 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 316 | 1.030 |
Why?
|
Coronavirus Infections | 2 | 2020 | 301 | 1.030 |
Why?
|
Health Care Rationing | 8 | 2017 | 83 | 1.020 |
Why?
|
Economics, Hospital | 3 | 2019 | 11 | 1.000 |
Why?
|
Data Collection | 14 | 2023 | 372 | 0.990 |
Why?
|
Vulnerable Populations | 3 | 2010 | 76 | 0.990 |
Why?
|
Dementia | 5 | 2020 | 187 | 0.980 |
Why?
|
Health Status Indicators | 5 | 2014 | 105 | 0.970 |
Why?
|
Interprofessional Relations | 5 | 2010 | 121 | 0.970 |
Why?
|
Hospital Mortality | 7 | 2022 | 349 | 0.960 |
Why?
|
Mortality | 4 | 2012 | 149 | 0.950 |
Why?
|
Health Literacy | 7 | 2020 | 70 | 0.950 |
Why?
|
Hospitals, University | 13 | 2013 | 194 | 0.950 |
Why?
|
Prospective Studies | 26 | 2023 | 4213 | 0.940 |
Why?
|
Models, Econometric | 5 | 2009 | 14 | 0.940 |
Why?
|
Social Support | 5 | 2018 | 193 | 0.930 |
Why?
|
Patient Readmission | 9 | 2022 | 329 | 0.930 |
Why?
|
Physicians, Family | 5 | 2010 | 40 | 0.920 |
Why?
|
Risk Management | 3 | 2009 | 43 | 0.920 |
Why?
|
Referral and Consultation | 5 | 2023 | 328 | 0.910 |
Why?
|
Drug Prescriptions | 6 | 2020 | 141 | 0.890 |
Why?
|
Emergency Service, Hospital | 4 | 2013 | 484 | 0.890 |
Why?
|
Cohort Studies | 22 | 2021 | 2767 | 0.880 |
Why?
|
Cross Infection | 3 | 2020 | 141 | 0.880 |
Why?
|
Interviews as Topic | 13 | 2018 | 319 | 0.880 |
Why?
|
Electronic Health Records | 8 | 2018 | 319 | 0.870 |
Why?
|
Comorbidity | 10 | 2021 | 943 | 0.870 |
Why?
|
Hospitals, Private | 1 | 2022 | 4 | 0.860 |
Why?
|
Workload | 5 | 2015 | 128 | 0.860 |
Why?
|
Hypertension | 6 | 2020 | 1141 | 0.850 |
Why?
|
Intensive Care Units | 7 | 2016 | 373 | 0.840 |
Why?
|
Hospital Bed Capacity | 2 | 2019 | 20 | 0.840 |
Why?
|
Insurance, Health | 7 | 2012 | 160 | 0.840 |
Why?
|
Patient Transfer | 5 | 2014 | 91 | 0.840 |
Why?
|
Prescription Fees | 2 | 2016 | 10 | 0.830 |
Why?
|
Family | 4 | 2018 | 311 | 0.820 |
Why?
|
Cross-Sectional Studies | 18 | 2022 | 1621 | 0.810 |
Why?
|
Public Health | 5 | 2016 | 129 | 0.810 |
Why?
|
Physician's Role | 5 | 2017 | 179 | 0.800 |
Why?
|
Patient Admission | 6 | 2019 | 112 | 0.800 |
Why?
|
Pandemics | 4 | 2023 | 740 | 0.790 |
Why?
|
Poverty | 2 | 2016 | 173 | 0.790 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2023 | 134 | 0.790 |
Why?
|
Retrospective Studies | 32 | 2023 | 8489 | 0.780 |
Why?
|
Computer Simulation | 3 | 2019 | 1078 | 0.780 |
Why?
|
Complementary Therapies | 1 | 2021 | 54 | 0.780 |
Why?
|
Attitude to Health | 9 | 2017 | 220 | 0.770 |
Why?
|
Nursing Homes | 4 | 2020 | 109 | 0.770 |
Why?
|
Pharmacogenomic Testing | 6 | 2022 | 97 | 0.760 |
Why?
|
Quarantine | 1 | 2020 | 8 | 0.750 |
Why?
|
Risk Factors | 20 | 2020 | 5417 | 0.750 |
Why?
|
Group Processes | 1 | 2020 | 31 | 0.740 |
Why?
|
Betacoronavirus | 2 | 2020 | 258 | 0.740 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 150 | 0.730 |
Why?
|
Physical Examination | 1 | 2021 | 149 | 0.730 |
Why?
|
Sex Characteristics | 1 | 2022 | 319 | 0.720 |
Why?
|
Healthcare Disparities | 3 | 2023 | 371 | 0.700 |
Why?
|
Decision Support Systems, Management | 1 | 2019 | 2 | 0.700 |
Why?
|
Drug Industry | 3 | 2023 | 54 | 0.700 |
Why?
|
Clinical Coding | 2 | 2017 | 23 | 0.700 |
Why?
|
Exercise | 4 | 2020 | 315 | 0.690 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2016 | 1373 | 0.690 |
Why?
|
Precision Medicine | 8 | 2022 | 395 | 0.690 |
Why?
|
Quality Improvement | 5 | 2016 | 428 | 0.670 |
Why?
|
Aspirin | 2 | 2018 | 156 | 0.670 |
Why?
|
Prevalence | 10 | 2023 | 1239 | 0.670 |
Why?
|
Medical Errors | 3 | 2009 | 115 | 0.660 |
Why?
|
Diabetes Complications | 4 | 2012 | 207 | 0.660 |
Why?
|
HIV Infections | 3 | 2015 | 772 | 0.650 |
Why?
|
Friends | 1 | 2018 | 17 | 0.640 |
Why?
|
Sepsis | 1 | 2022 | 306 | 0.640 |
Why?
|
Research Support as Topic | 3 | 2012 | 80 | 0.630 |
Why?
|
Diabetes Mellitus | 5 | 2014 | 806 | 0.630 |
Why?
|
Hospital Administration | 3 | 2019 | 26 | 0.620 |
Why?
|
Social Isolation | 1 | 2018 | 67 | 0.620 |
Why?
|
Sleep Deprivation | 4 | 2019 | 137 | 0.620 |
Why?
|
Patients' Rooms | 1 | 2017 | 14 | 0.610 |
Why?
|
Hospices | 1 | 2017 | 7 | 0.610 |
Why?
|
Secondary Prevention | 1 | 2018 | 162 | 0.610 |
Why?
|
Colonic Diseases | 2 | 2017 | 65 | 0.610 |
Why?
|
Models, Statistical | 9 | 2016 | 574 | 0.600 |
Why?
|
Chronic Disease | 4 | 2020 | 971 | 0.600 |
Why?
|
Therapeutics | 1 | 2016 | 12 | 0.590 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 65 | 0.590 |
Why?
|
Regression Analysis | 7 | 2017 | 596 | 0.580 |
Why?
|
Job Satisfaction | 2 | 2008 | 73 | 0.580 |
Why?
|
Tissue and Organ Procurement | 6 | 2016 | 311 | 0.580 |
Why?
|
Gastroenterologists | 1 | 2017 | 30 | 0.580 |
Why?
|
Practice Guidelines as Topic | 6 | 2019 | 1036 | 0.580 |
Why?
|
Spinal Cord Injuries | 1 | 2017 | 54 | 0.580 |
Why?
|
Research | 5 | 2019 | 253 | 0.570 |
Why?
|
Career Choice | 2 | 2009 | 139 | 0.570 |
Why?
|
Research Design | 8 | 2019 | 594 | 0.570 |
Why?
|
Social Security | 1 | 2016 | 5 | 0.570 |
Why?
|
Blood Glucose | 5 | 2016 | 873 | 0.570 |
Why?
|
Hemoglobins | 3 | 2022 | 179 | 0.560 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 56 | 0.550 |
Why?
|
Models, Economic | 6 | 2018 | 60 | 0.550 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2017 | 247 | 0.550 |
Why?
|
Financing, Personal | 3 | 2005 | 21 | 0.550 |
Why?
|
Sleep Apnea Syndromes | 2 | 2014 | 103 | 0.550 |
Why?
|
Models, Theoretical | 5 | 2011 | 482 | 0.540 |
Why?
|
Age Factors | 12 | 2018 | 1851 | 0.540 |
Why?
|
Acute Disease | 2 | 2015 | 826 | 0.540 |
Why?
|
Biomedical Research | 4 | 2018 | 376 | 0.530 |
Why?
|
Ambulatory Care | 3 | 2023 | 181 | 0.530 |
Why?
|
Health Resources | 2 | 2013 | 76 | 0.530 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 73 | 0.530 |
Why?
|
Health Services Accessibility | 7 | 2020 | 394 | 0.530 |
Why?
|
Laryngectomy | 1 | 2015 | 26 | 0.530 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 37 | 0.520 |
Why?
|
Work Schedule Tolerance | 4 | 2008 | 36 | 0.520 |
Why?
|
Colonoscopy | 1 | 2017 | 264 | 0.520 |
Why?
|
Anti-Retroviral Agents | 1 | 2015 | 30 | 0.520 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 746 | 0.520 |
Why?
|
Education, Medical, Graduate | 6 | 2017 | 369 | 0.510 |
Why?
|
Terminal Care | 3 | 2016 | 130 | 0.510 |
Why?
|
Time Factors | 21 | 2019 | 5210 | 0.500 |
Why?
|
Coronary Disease | 3 | 2006 | 261 | 0.500 |
Why?
|
Laryngeal Neoplasms | 1 | 2015 | 89 | 0.500 |
Why?
|
Self Care | 4 | 2016 | 164 | 0.500 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 71 | 0.500 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 2014 | 3 | 0.500 |
Why?
|
Constipation | 1 | 2015 | 63 | 0.500 |
Why?
|
Diffusion of Innovation | 2 | 2012 | 71 | 0.490 |
Why?
|
Comprehensive Health Care | 1 | 2014 | 13 | 0.490 |
Why?
|
Hypoglycemic Agents | 2 | 2008 | 378 | 0.490 |
Why?
|
Health Surveys | 6 | 2013 | 239 | 0.490 |
Why?
|
Treatment Outcome | 15 | 2020 | 7993 | 0.490 |
Why?
|
Hospital Medicine | 1 | 2014 | 19 | 0.480 |
Why?
|
Investments | 2 | 2012 | 6 | 0.480 |
Why?
|
Drug Therapy | 3 | 2015 | 70 | 0.480 |
Why?
|
Antipsychotic Agents | 2 | 2009 | 123 | 0.480 |
Why?
|
Government Regulation | 5 | 2009 | 49 | 0.470 |
Why?
|
Multivariate Analysis | 10 | 2017 | 999 | 0.470 |
Why?
|
Information Services | 1 | 2013 | 23 | 0.460 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 184 | 0.460 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2019 | 508 | 0.460 |
Why?
|
Upper Gastrointestinal Tract | 2 | 2010 | 10 | 0.450 |
Why?
|
Heart Arrest | 5 | 2016 | 265 | 0.450 |
Why?
|
Interdisciplinary Communication | 2 | 2010 | 130 | 0.450 |
Why?
|
Text Messaging | 1 | 2013 | 27 | 0.450 |
Why?
|
Qualitative Research | 6 | 2020 | 256 | 0.450 |
Why?
|
Food Hypersensitivity | 1 | 2013 | 63 | 0.440 |
Why?
|
International Classification of Diseases | 4 | 2017 | 69 | 0.440 |
Why?
|
Adolescent | 18 | 2022 | 8981 | 0.440 |
Why?
|
Caregivers | 2 | 2013 | 151 | 0.430 |
Why?
|
Diagnostic Errors | 1 | 2013 | 160 | 0.430 |
Why?
|
Elective Surgical Procedures | 1 | 2013 | 116 | 0.430 |
Why?
|
Genomics | 2 | 2019 | 720 | 0.430 |
Why?
|
Intubation, Intratracheal | 1 | 2013 | 144 | 0.430 |
Why?
|
Medication Errors | 2 | 2013 | 39 | 0.420 |
Why?
|
Advance Directives | 2 | 2012 | 64 | 0.420 |
Why?
|
Medical Oncology | 2 | 2019 | 359 | 0.420 |
Why?
|
Incidence | 5 | 2021 | 1577 | 0.420 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2017 | 50 | 0.410 |
Why?
|
Drug Approval | 3 | 2012 | 62 | 0.410 |
Why?
|
Teaching | 3 | 2023 | 147 | 0.410 |
Why?
|
Morbidity | 1 | 2012 | 148 | 0.410 |
Why?
|
Night Care | 1 | 2011 | 9 | 0.410 |
Why?
|
Patient Care | 4 | 2023 | 100 | 0.400 |
Why?
|
Income | 2 | 2010 | 75 | 0.400 |
Why?
|
Contraceptives, Oral | 3 | 2020 | 46 | 0.400 |
Why?
|
Clinical Competence | 8 | 2020 | 751 | 0.400 |
Why?
|
Decision Support Systems, Clinical | 5 | 2019 | 103 | 0.400 |
Why?
|
Aging | 3 | 2020 | 691 | 0.400 |
Why?
|
Communication Barriers | 3 | 2010 | 29 | 0.390 |
Why?
|
Bariatric Surgery | 1 | 2013 | 194 | 0.390 |
Why?
|
Social Sciences | 2 | 2009 | 5 | 0.390 |
Why?
|
Malaysia | 2 | 2021 | 12 | 0.390 |
Why?
|
Health Services Needs and Demand | 3 | 2020 | 102 | 0.390 |
Why?
|
Obesity, Morbid | 1 | 2013 | 225 | 0.380 |
Why?
|
Patient Safety | 2 | 2015 | 212 | 0.380 |
Why?
|
Health Care Sector | 2 | 2009 | 13 | 0.380 |
Why?
|
Longitudinal Studies | 4 | 2022 | 1019 | 0.380 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 827 | 0.380 |
Why?
|
Evidence-Based Medicine | 3 | 2014 | 429 | 0.380 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2011 | 567 | 0.380 |
Why?
|
Illinois | 8 | 2022 | 462 | 0.380 |
Why?
|
Risk Adjustment | 3 | 2018 | 39 | 0.380 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 219 | 0.380 |
Why?
|
Sickness Impact Profile | 1 | 2010 | 27 | 0.370 |
Why?
|
Mental Health | 2 | 2009 | 162 | 0.370 |
Why?
|
Patient Education as Topic | 5 | 2017 | 351 | 0.370 |
Why?
|
Motivation | 2 | 2010 | 287 | 0.370 |
Why?
|
Nurse Practitioners | 2 | 2020 | 32 | 0.370 |
Why?
|
Environmental Health | 1 | 2009 | 7 | 0.360 |
Why?
|
Global Warming | 1 | 2009 | 6 | 0.360 |
Why?
|
Waiting Lists | 3 | 2013 | 175 | 0.360 |
Why?
|
Drugs, Generic | 2 | 2020 | 21 | 0.360 |
Why?
|
Confidentiality | 5 | 2016 | 78 | 0.360 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2009 | 33 | 0.360 |
Why?
|
Self Concept | 1 | 2010 | 133 | 0.360 |
Why?
|
Personnel, Hospital | 3 | 2020 | 30 | 0.350 |
Why?
|
Forms and Records Control | 1 | 2009 | 16 | 0.350 |
Why?
|
Drug Discovery | 1 | 2010 | 103 | 0.350 |
Why?
|
Decision Trees | 1 | 2009 | 63 | 0.350 |
Why?
|
Proton Pump Inhibitors | 1 | 2009 | 31 | 0.350 |
Why?
|
Medication Systems, Hospital | 2 | 2013 | 7 | 0.350 |
Why?
|
Sexual Partners | 1 | 2010 | 93 | 0.350 |
Why?
|
Patient Outcome Assessment | 2 | 2023 | 84 | 0.340 |
Why?
|
Sex Factors | 7 | 2020 | 1054 | 0.340 |
Why?
|
Students, Medical | 4 | 2012 | 384 | 0.340 |
Why?
|
Outpatients | 1 | 2009 | 94 | 0.340 |
Why?
|
Guideline Adherence | 4 | 2018 | 223 | 0.340 |
Why?
|
Prescription Drugs | 2 | 2019 | 36 | 0.330 |
Why?
|
Physical Fitness | 1 | 2009 | 51 | 0.330 |
Why?
|
Perception | 5 | 2015 | 168 | 0.330 |
Why?
|
Anesthesiology | 2 | 2022 | 157 | 0.330 |
Why?
|
Safety | 1 | 2009 | 152 | 0.330 |
Why?
|
Patient Care Planning | 1 | 2008 | 81 | 0.320 |
Why?
|
Frail Elderly | 2 | 2010 | 71 | 0.320 |
Why?
|
Life Expectancy | 8 | 2015 | 86 | 0.320 |
Why?
|
Activities of Daily Living | 3 | 2022 | 204 | 0.320 |
Why?
|
Dyssomnias | 1 | 2007 | 7 | 0.310 |
Why?
|
Hygiene | 1 | 2007 | 10 | 0.310 |
Why?
|
Models, Educational | 4 | 2017 | 50 | 0.310 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2008 | 64 | 0.310 |
Why?
|
Neoplasms | 4 | 2019 | 2898 | 0.310 |
Why?
|
Mental Fatigue | 1 | 2007 | 9 | 0.310 |
Why?
|
Anxiety | 2 | 2011 | 287 | 0.310 |
Why?
|
Patients | 4 | 2020 | 100 | 0.310 |
Why?
|
Cooperative Behavior | 4 | 2015 | 174 | 0.300 |
Why?
|
Residence Characteristics | 3 | 2018 | 197 | 0.300 |
Why?
|
Anti-HIV Agents | 1 | 2009 | 149 | 0.300 |
Why?
|
Anemia, Sickle Cell | 1 | 2009 | 131 | 0.300 |
Why?
|
Personality Inventory | 1 | 2007 | 108 | 0.290 |
Why?
|
Young Adult | 13 | 2017 | 5976 | 0.290 |
Why?
|
Prognosis | 6 | 2016 | 3679 | 0.290 |
Why?
|
Biopsy, Needle | 1 | 2007 | 235 | 0.290 |
Why?
|
Spirituality | 3 | 2012 | 87 | 0.290 |
Why?
|
Health Services | 4 | 2018 | 55 | 0.290 |
Why?
|
Metered Dose Inhalers | 2 | 2017 | 33 | 0.280 |
Why?
|
Sleep Wake Disorders | 2 | 2019 | 115 | 0.280 |
Why?
|
Vascular Diseases | 1 | 2007 | 121 | 0.280 |
Why?
|
Anxiety Disorders | 1 | 2007 | 148 | 0.280 |
Why?
|
Data Interpretation, Statistical | 3 | 2018 | 297 | 0.280 |
Why?
|
Severity of Illness Index | 9 | 2018 | 1801 | 0.270 |
Why?
|
Blood Transfusion | 3 | 2023 | 157 | 0.270 |
Why?
|
Geriatric Assessment | 5 | 2019 | 166 | 0.270 |
Why?
|
Clinical Decision-Making | 2 | 2019 | 257 | 0.270 |
Why?
|
Heart Failure | 2 | 2013 | 1204 | 0.270 |
Why?
|
Vision, Low | 2 | 2015 | 15 | 0.270 |
Why?
|
Heartburn | 1 | 2005 | 9 | 0.270 |
Why?
|
Access to Information | 3 | 2017 | 27 | 0.270 |
Why?
|
Medical Order Entry Systems | 2 | 2017 | 25 | 0.270 |
Why?
|
Educational Status | 4 | 2013 | 188 | 0.270 |
Why?
|
Marital Status | 2 | 2019 | 40 | 0.260 |
Why?
|
Self Disclosure | 1 | 2005 | 31 | 0.260 |
Why?
|
Mass Screening | 3 | 2015 | 618 | 0.260 |
Why?
|
Nonprescription Drugs | 1 | 2005 | 15 | 0.260 |
Why?
|
Pain | 3 | 2022 | 391 | 0.260 |
Why?
|
Family Practice | 4 | 2010 | 84 | 0.260 |
Why?
|
Antiviral Agents | 2 | 2022 | 510 | 0.260 |
Why?
|
Machine Learning | 2 | 2018 | 232 | 0.260 |
Why?
|
Odds Ratio | 6 | 2019 | 678 | 0.250 |
Why?
|
Critical Care | 2 | 2019 | 370 | 0.250 |
Why?
|
Information Dissemination | 2 | 2016 | 103 | 0.250 |
Why?
|
Hypercholesterolemia | 1 | 2006 | 161 | 0.250 |
Why?
|
Clinical Clerkship | 1 | 2006 | 116 | 0.250 |
Why?
|
Heart Diseases | 1 | 2007 | 290 | 0.250 |
Why?
|
Cholesterol, LDL | 1 | 2005 | 222 | 0.250 |
Why?
|
Vision Disorders | 2 | 2016 | 75 | 0.250 |
Why?
|
Health Information Exchange | 2 | 2015 | 12 | 0.250 |
Why?
|
Perioperative Care | 3 | 2022 | 161 | 0.250 |
Why?
|
Forecasting | 7 | 2019 | 304 | 0.240 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 364 | 0.240 |
Why?
|
Pyrimidinones | 1 | 2023 | 36 | 0.240 |
Why?
|
Vitamins | 2 | 2022 | 81 | 0.230 |
Why?
|
ROC Curve | 4 | 2016 | 752 | 0.230 |
Why?
|
Professional Autonomy | 3 | 2014 | 41 | 0.230 |
Why?
|
Medical Record Linkage | 4 | 2015 | 17 | 0.230 |
Why?
|
Cost Control | 3 | 2014 | 44 | 0.230 |
Why?
|
Postoperative Complications | 1 | 2013 | 2207 | 0.230 |
Why?
|
Transplantation | 1 | 2003 | 39 | 0.230 |
Why?
|
Religion | 3 | 2012 | 87 | 0.230 |
Why?
|
Ticlopidine | 1 | 2023 | 25 | 0.220 |
Why?
|
Health Care Surveys | 3 | 2010 | 278 | 0.220 |
Why?
|
United Kingdom | 5 | 2019 | 164 | 0.220 |
Why?
|
Pharmacists | 1 | 2022 | 32 | 0.220 |
Why?
|
Point-of-Care Systems | 3 | 2019 | 141 | 0.220 |
Why?
|
Lung Transplantation | 2 | 2016 | 175 | 0.220 |
Why?
|
Respiration, Artificial | 2 | 2016 | 334 | 0.220 |
Why?
|
Trust | 2 | 2021 | 95 | 0.220 |
Why?
|
Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 238 | 0.210 |
Why?
|
Managed Competition | 1 | 2002 | 2 | 0.210 |
Why?
|
Drug Labeling | 3 | 2017 | 41 | 0.210 |
Why?
|
Prospective Payment System | 1 | 2002 | 7 | 0.210 |
Why?
|
Tramadol | 1 | 2022 | 14 | 0.210 |
Why?
|
Mind-Body Therapies | 1 | 2021 | 3 | 0.210 |
Why?
|
India | 1 | 2022 | 120 | 0.210 |
Why?
|
Reproducibility of Results | 7 | 2013 | 2705 | 0.210 |
Why?
|
Documentation | 3 | 2013 | 98 | 0.200 |
Why?
|
Medicine | 3 | 2016 | 89 | 0.200 |
Why?
|
Nursing Staff, Hospital | 2 | 2019 | 42 | 0.200 |
Why?
|
Prostatectomy | 2 | 2005 | 471 | 0.200 |
Why?
|
Tissue Donors | 2 | 2016 | 463 | 0.200 |
Why?
|
Self Efficacy | 2 | 2013 | 53 | 0.200 |
Why?
|
Obesity | 1 | 2008 | 963 | 0.200 |
Why?
|
Weight Lifting | 1 | 2020 | 7 | 0.200 |
Why?
|
Oral Health | 1 | 2020 | 10 | 0.200 |
Why?
|
Asthma | 3 | 2017 | 955 | 0.200 |
Why?
|
Program Development | 6 | 2017 | 124 | 0.190 |
Why?
|
Calcifediol | 1 | 2020 | 21 | 0.190 |
Why?
|
Patient Selection | 4 | 2018 | 685 | 0.190 |
Why?
|
Societies, Medical | 2 | 2020 | 572 | 0.190 |
Why?
|
Warfarin | 3 | 2019 | 103 | 0.190 |
Why?
|
Athletes | 1 | 2020 | 46 | 0.190 |
Why?
|
Athletic Performance | 1 | 2020 | 31 | 0.190 |
Why?
|
Value of Life | 1 | 2000 | 22 | 0.190 |
Why?
|
Symptom Assessment | 1 | 2020 | 65 | 0.190 |
Why?
|
Intubation, Gastrointestinal | 1 | 2020 | 31 | 0.190 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 2360 | 0.190 |
Why?
|
Antibody Formation | 1 | 2020 | 171 | 0.180 |
Why?
|
Resuscitation Orders | 2 | 2012 | 62 | 0.180 |
Why?
|
Anesthesia | 1 | 2022 | 164 | 0.180 |
Why?
|
Learning | 1 | 2003 | 280 | 0.180 |
Why?
|
Psychometrics | 4 | 2011 | 327 | 0.180 |
Why?
|
Disease Management | 3 | 2019 | 327 | 0.180 |
Why?
|
Social Class | 3 | 2013 | 128 | 0.180 |
Why?
|
Host-Pathogen Interactions | 1 | 2022 | 231 | 0.180 |
Why?
|
Aftercare | 1 | 2020 | 85 | 0.180 |
Why?
|
Calcitriol | 1 | 2020 | 174 | 0.180 |
Why?
|
Life Style | 2 | 2020 | 189 | 0.180 |
Why?
|
Markov Chains | 2 | 2018 | 125 | 0.180 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2015 | 350 | 0.170 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 383 | 0.170 |
Why?
|
Follow-Up Studies | 5 | 2018 | 3640 | 0.170 |
Why?
|
Antibodies, Viral | 1 | 2020 | 293 | 0.170 |
Why?
|
Social Determinants of Health | 1 | 2020 | 78 | 0.170 |
Why?
|
Pediatrics | 1 | 2003 | 344 | 0.170 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2018 | 16 | 0.170 |
Why?
|
Pilot Projects | 4 | 2016 | 839 | 0.170 |
Why?
|
Radiotherapy | 1 | 2001 | 328 | 0.170 |
Why?
|
Pharmacogenomic Variants | 1 | 2019 | 41 | 0.170 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2011 | 190 | 0.160 |
Why?
|
Immunity, Innate | 1 | 2022 | 409 | 0.160 |
Why?
|
Education, Medical, Continuing | 2 | 2010 | 107 | 0.160 |
Why?
|
Pain Management | 1 | 2019 | 127 | 0.160 |
Why?
|
Linear Models | 4 | 2016 | 421 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 2357 | 0.160 |
Why?
|
Telemedicine | 1 | 2020 | 169 | 0.160 |
Why?
|
Family Health | 2 | 2013 | 162 | 0.160 |
Why?
|
Biological Products | 1 | 2019 | 143 | 0.150 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 162 | 0.150 |
Why?
|
Cardiology | 2 | 2011 | 123 | 0.150 |
Why?
|
United States Agency for Healthcare Research and Quality | 2 | 2014 | 6 | 0.150 |
Why?
|
Social Networking | 1 | 2018 | 75 | 0.150 |
Why?
|
Insurance Claim Review | 1 | 2017 | 41 | 0.150 |
Why?
|
Medical Overuse | 1 | 2017 | 36 | 0.150 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 69 | 0.150 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 1686 | 0.150 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2018 | 166 | 0.150 |
Why?
|
Microcomputers | 1 | 2016 | 26 | 0.150 |
Why?
|
Mitral Valve | 1 | 2018 | 248 | 0.150 |
Why?
|
Physical Education and Training | 1 | 1996 | 3 | 0.140 |
Why?
|
Mitral Valve Insufficiency | 1 | 2018 | 187 | 0.140 |
Why?
|
Health Services Misuse | 2 | 2013 | 19 | 0.140 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 199 | 0.140 |
Why?
|
Respiratory System Agents | 1 | 2016 | 7 | 0.140 |
Why?
|
Accidental Falls | 1 | 2016 | 50 | 0.140 |
Why?
|
Liver Transplantation | 3 | 2003 | 1268 | 0.140 |
Why?
|
Vital Signs | 2 | 2016 | 38 | 0.140 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 45 | 0.140 |
Why?
|
Renal Dialysis | 2 | 2013 | 355 | 0.140 |
Why?
|
Face | 1 | 2016 | 114 | 0.140 |
Why?
|
Hospitals, General | 1 | 2015 | 12 | 0.140 |
Why?
|
Developing Countries | 1 | 2016 | 71 | 0.140 |
Why?
|
Health Equity | 1 | 2017 | 77 | 0.140 |
Why?
|
Osteoarthritis, Hip | 1 | 2015 | 23 | 0.130 |
Why?
|
Child | 7 | 2022 | 6927 | 0.130 |
Why?
|
Public Policy | 2 | 2010 | 52 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2016 | 176 | 0.130 |
Why?
|
Eyeglasses | 1 | 2015 | 8 | 0.130 |
Why?
|
Attitude to Death | 2 | 2012 | 36 | 0.130 |
Why?
|
Schizophrenia | 1 | 1999 | 464 | 0.130 |
Why?
|
Budgets | 1 | 2014 | 10 | 0.130 |
Why?
|
Midwestern United States | 3 | 2007 | 76 | 0.130 |
Why?
|
Monte Carlo Method | 3 | 2007 | 185 | 0.130 |
Why?
|
Medical Records | 1 | 2015 | 119 | 0.130 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 63 | 0.130 |
Why?
|
Diagnosis-Related Groups | 2 | 2005 | 20 | 0.130 |
Why?
|
Program Evaluation | 4 | 2011 | 297 | 0.130 |
Why?
|
Memory Disorders | 1 | 2015 | 69 | 0.130 |
Why?
|
Health Behavior | 1 | 1996 | 183 | 0.130 |
Why?
|
Career Mobility | 2 | 2014 | 31 | 0.120 |
Why?
|
Computer Communication Networks | 1 | 2014 | 23 | 0.120 |
Why?
|
Palliative Care | 1 | 2016 | 257 | 0.120 |
Why?
|
Workplace | 3 | 2012 | 27 | 0.120 |
Why?
|
Time-to-Treatment | 1 | 2015 | 98 | 0.120 |
Why?
|
Statistics as Topic | 2 | 2007 | 238 | 0.120 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2012 | 59 | 0.120 |
Why?
|
Physician Impairment | 1 | 2014 | 6 | 0.120 |
Why?
|
State Medicine | 2 | 2017 | 12 | 0.120 |
Why?
|
Predictive Value of Tests | 3 | 2011 | 1673 | 0.120 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 126 | 0.120 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 1991 | 0.120 |
Why?
|
Algorithms | 3 | 2015 | 1830 | 0.120 |
Why?
|
Prostate-Specific Antigen | 2 | 2007 | 353 | 0.120 |
Why?
|
Genome, Human | 1 | 2019 | 756 | 0.120 |
Why?
|
Lung Diseases | 1 | 2016 | 263 | 0.120 |
Why?
|
Meaningful Use | 1 | 2013 | 2 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 1961 | 0.120 |
Why?
|
Liver Diseases | 2 | 2014 | 238 | 0.120 |
Why?
|
Enteral Nutrition | 1 | 2014 | 102 | 0.120 |
Why?
|
Occupational Health | 1 | 2014 | 32 | 0.120 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2015 | 102 | 0.120 |
Why?
|
Social Values | 1 | 2013 | 44 | 0.120 |
Why?
|
Dizziness | 1 | 2013 | 27 | 0.120 |
Why?
|
Electronic Prescribing | 1 | 2013 | 11 | 0.120 |
Why?
|
Emergency Treatment | 1 | 2013 | 39 | 0.120 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2015 | 111 | 0.120 |
Why?
|
Urologists | 2 | 2023 | 24 | 0.120 |
Why?
|
Vitamin K Epoxide Reductases | 1 | 2013 | 16 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2013 | 41 | 0.110 |
Why?
|
Emergencies | 1 | 2013 | 113 | 0.110 |
Why?
|
Academies and Institutes | 1 | 2013 | 31 | 0.110 |
Why?
|
Community Participation | 1 | 2013 | 36 | 0.110 |
Why?
|
Memory | 1 | 2015 | 225 | 0.110 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2012 | 24 | 0.110 |
Why?
|
Motor Activity | 1 | 2015 | 327 | 0.110 |
Why?
|
Names | 1 | 2012 | 10 | 0.110 |
Why?
|
School Admission Criteria | 1 | 2012 | 23 | 0.110 |
Why?
|
Language | 1 | 2014 | 151 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2014 | 94 | 0.110 |
Why?
|
Thromboembolism | 1 | 2013 | 119 | 0.110 |
Why?
|
Huntington Disease | 1 | 2012 | 37 | 0.110 |
Why?
|
Specialization | 2 | 2008 | 65 | 0.110 |
Why?
|
Noise | 1 | 2012 | 27 | 0.100 |
Why?
|
Treatment Refusal | 1 | 2012 | 60 | 0.100 |
Why?
|
Mental Disorders | 1 | 2015 | 371 | 0.100 |
Why?
|
Triage | 1 | 2012 | 108 | 0.100 |
Why?
|
Competency-Based Education | 2 | 2008 | 35 | 0.100 |
Why?
|
Military Personnel | 1 | 2012 | 85 | 0.100 |
Why?
|
Software | 1 | 2015 | 654 | 0.100 |
Why?
|
Vital Capacity | 1 | 2011 | 64 | 0.100 |
Why?
|
Computer Security | 3 | 2015 | 16 | 0.100 |
Why?
|
Psychology, Industrial | 1 | 2010 | 2 | 0.100 |
Why?
|
Educational Measurement | 1 | 2013 | 225 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 57 | 0.100 |
Why?
|
Guidelines as Topic | 3 | 2019 | 162 | 0.100 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 122 | 0.100 |
Why?
|
Multilingualism | 1 | 2010 | 10 | 0.090 |
Why?
|
Internet | 3 | 2020 | 312 | 0.090 |
Why?
|
Education | 1 | 2010 | 58 | 0.090 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2010 | 8 | 0.090 |
Why?
|
Economics | 1 | 2010 | 11 | 0.090 |
Why?
|
Age Distribution | 3 | 2012 | 204 | 0.090 |
Why?
|
Off-Label Use | 1 | 2010 | 16 | 0.090 |
Why?
|
Advisory Committees | 1 | 2010 | 90 | 0.090 |
Why?
|
Goals | 1 | 2010 | 67 | 0.090 |
Why?
|
Colorectal Neoplasms | 1 | 1998 | 938 | 0.090 |
Why?
|
Survival Analysis | 4 | 2016 | 1538 | 0.090 |
Why?
|
Databases, Factual | 1 | 2013 | 814 | 0.090 |
Why?
|
Awareness | 1 | 2010 | 93 | 0.090 |
Why?
|
Peptic Ulcer Hemorrhage | 1 | 2009 | 9 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 462 | 0.090 |
Why?
|
Policy | 1 | 2010 | 34 | 0.090 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2010 | 57 | 0.090 |
Why?
|
Personnel Selection | 1 | 2010 | 59 | 0.090 |
Why?
|
Policy Making | 2 | 2020 | 62 | 0.090 |
Why?
|
Physical Therapy Modalities | 2 | 2023 | 84 | 0.090 |
Why?
|
Environmental Pollution | 1 | 2009 | 13 | 0.090 |
Why?
|
Cause of Death | 1 | 2010 | 277 | 0.090 |
Why?
|
Blood Pressure | 2 | 2012 | 1143 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 98 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2009 | 71 | 0.090 |
Why?
|
Leadership | 1 | 2010 | 134 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2008 | 170 | 0.080 |
Why?
|
Affect | 1 | 2011 | 386 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2012 | 1204 | 0.080 |
Why?
|
Focus Groups | 2 | 2020 | 155 | 0.080 |
Why?
|
Carbon Dioxide | 1 | 2009 | 188 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 521 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 153 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2011 | 209 | 0.080 |
Why?
|
Organizations, Nonprofit | 1 | 2008 | 8 | 0.080 |
Why?
|
Infant | 2 | 2013 | 3046 | 0.080 |
Why?
|
Air Pollution | 1 | 2009 | 68 | 0.080 |
Why?
|
Health Services for the Aged | 1 | 2008 | 27 | 0.080 |
Why?
|
Biomedical Technology | 1 | 2008 | 20 | 0.080 |
Why?
|
Counseling | 1 | 2010 | 145 | 0.080 |
Why?
|
Blood Banks | 1 | 2008 | 7 | 0.080 |
Why?
|
Child, Preschool | 2 | 2013 | 3612 | 0.080 |
Why?
|
Fees, Pharmaceutical | 1 | 2008 | 4 | 0.080 |
Why?
|
Medicare Part D | 1 | 2008 | 10 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2008 | 30 | 0.080 |
Why?
|
Empirical Research | 1 | 2007 | 19 | 0.080 |
Why?
|
Accreditation | 1 | 2008 | 60 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2009 | 182 | 0.080 |
Why?
|
Gastroenterology | 1 | 2010 | 134 | 0.080 |
Why?
|
Information Storage and Retrieval | 2 | 2021 | 120 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2010 | 912 | 0.080 |
Why?
|
Organ Transplantation | 2 | 2003 | 265 | 0.080 |
Why?
|
Fetal Blood | 1 | 2008 | 90 | 0.080 |
Why?
|
Uncertainty | 1 | 2008 | 71 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2008 | 58 | 0.080 |
Why?
|
Hospital Charges | 2 | 2012 | 29 | 0.080 |
Why?
|
Sick Role | 1 | 2007 | 13 | 0.080 |
Why?
|
China | 1 | 2008 | 228 | 0.080 |
Why?
|
Rural Population | 1 | 2008 | 136 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 243 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2010 | 230 | 0.080 |
Why?
|
Patient Compliance | 1 | 2008 | 227 | 0.070 |
Why?
|
Delirium | 1 | 2007 | 66 | 0.070 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2008 | 93 | 0.070 |
Why?
|
Occupational Health Services | 1 | 2006 | 4 | 0.070 |
Why?
|
Actigraphy | 2 | 2017 | 51 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2003 | 509 | 0.070 |
Why?
|
Urban Population | 1 | 2008 | 213 | 0.070 |
Why?
|
Community Health Centers | 1 | 2007 | 113 | 0.070 |
Why?
|
Personal Satisfaction | 1 | 2006 | 62 | 0.070 |
Why?
|
Survival Rate | 1 | 2010 | 1863 | 0.070 |
Why?
|
Biopsy | 2 | 2011 | 1163 | 0.070 |
Why?
|
Postoperative Period | 1 | 2007 | 303 | 0.070 |
Why?
|
Administration, Inhalation | 2 | 2017 | 188 | 0.070 |
Why?
|
Genetic Variation | 1 | 2013 | 1351 | 0.070 |
Why?
|
Factor Analysis, Statistical | 1 | 2006 | 111 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2007 | 218 | 0.070 |
Why?
|
Health Education | 1 | 2006 | 101 | 0.070 |
Why?
|
Diabetic Neuropathies | 1 | 2006 | 40 | 0.070 |
Why?
|
Bacteria | 1 | 2009 | 447 | 0.070 |
Why?
|
Self Report | 2 | 2020 | 288 | 0.070 |
Why?
|
Education, Medical | 1 | 2008 | 233 | 0.070 |
Why?
|
Bayes Theorem | 1 | 2007 | 361 | 0.070 |
Why?
|
Consumer Behavior | 1 | 2005 | 29 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2006 | 399 | 0.070 |
Why?
|
Diabetic Retinopathy | 1 | 2006 | 87 | 0.060 |
Why?
|
Diet | 1 | 2008 | 443 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 865 | 0.060 |
Why?
|
Geography | 2 | 2016 | 223 | 0.060 |
Why?
|
Fever of Unknown Origin | 1 | 2003 | 5 | 0.060 |
Why?
|
Industry | 1 | 2023 | 16 | 0.060 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2003 | 5 | 0.060 |
Why?
|
Pyrrolidines | 1 | 2023 | 58 | 0.060 |
Why?
|
Hospital Rapid Response Team | 2 | 2014 | 27 | 0.060 |
Why?
|
Cytochrome P-450 CYP2C19 | 1 | 2023 | 7 | 0.060 |
Why?
|
Diabetic Nephropathies | 1 | 2006 | 248 | 0.060 |
Why?
|
Hematuria | 1 | 2023 | 49 | 0.060 |
Why?
|
Cholecalciferol | 1 | 2022 | 35 | 0.060 |
Why?
|
Consensus | 2 | 2016 | 335 | 0.050 |
Why?
|
Omeprazole | 1 | 2022 | 11 | 0.050 |
Why?
|
Succinylcholine | 1 | 2022 | 14 | 0.050 |
Why?
|
Hydralazine | 1 | 2022 | 20 | 0.050 |
Why?
|
A549 Cells | 1 | 2022 | 39 | 0.050 |
Why?
|
Proxy | 2 | 2012 | 24 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 100 | 0.050 |
Why?
|
Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2022 | 128 | 0.050 |
Why?
|
Oxycodone | 1 | 2022 | 35 | 0.050 |
Why?
|
California | 1 | 2002 | 138 | 0.050 |
Why?
|
Translating | 1 | 2001 | 18 | 0.050 |
Why?
|
Health Maintenance Organizations | 1 | 2001 | 20 | 0.050 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2022 | 83 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2022 | 90 | 0.050 |
Why?
|
Interferons | 1 | 2022 | 133 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2003 | 916 | 0.050 |
Why?
|
Papanicolaou Test | 1 | 2001 | 38 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2013 | 122 | 0.050 |
Why?
|
Genotype | 2 | 2019 | 1851 | 0.050 |
Why?
|
Blood Pressure Determination | 2 | 2012 | 90 | 0.050 |
Why?
|
Endoribonucleases | 1 | 2022 | 92 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2001 | 68 | 0.050 |
Why?
|
Housing | 1 | 2021 | 42 | 0.050 |
Why?
|
Social Welfare | 1 | 2001 | 19 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2001 | 62 | 0.050 |
Why?
|
Professional Competence | 1 | 2001 | 68 | 0.050 |
Why?
|
Curriculum | 2 | 2020 | 539 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2011 | 229 | 0.050 |
Why?
|
Menopause | 1 | 2020 | 71 | 0.050 |
Why?
|
Insulin | 1 | 2006 | 1160 | 0.050 |
Why?
|
Virus Replication | 1 | 2022 | 319 | 0.050 |
Why?
|
Parents | 1 | 2023 | 272 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2013 | 127 | 0.050 |
Why?
|
SEER Program | 1 | 2001 | 190 | 0.050 |
Why?
|
Ethnobotany | 1 | 2019 | 1 | 0.050 |
Why?
|
Ethics Committees | 1 | 2000 | 8 | 0.050 |
Why?
|
Ethicists | 1 | 2000 | 20 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2020 | 112 | 0.050 |
Why?
|
Ethics Consultation | 1 | 2000 | 12 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2020 | 106 | 0.050 |
Why?
|
United States Public Health Service | 1 | 1999 | 3 | 0.050 |
Why?
|
Blindness | 1 | 2000 | 41 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 104 | 0.040 |
Why?
|
Bias | 1 | 2000 | 127 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 1169 | 0.040 |
Why?
|
Resource Allocation | 1 | 2000 | 65 | 0.040 |
Why?
|
Leg | 1 | 2000 | 137 | 0.040 |
Why?
|
Computational Biology | 1 | 2023 | 528 | 0.040 |
Why?
|
Drug Recalls | 1 | 2019 | 13 | 0.040 |
Why?
|
Codeine | 1 | 2019 | 12 | 0.040 |
Why?
|
Mobility Limitation | 1 | 2019 | 19 | 0.040 |
Why?
|
Biomarkers, Tumor | 1 | 2007 | 1464 | 0.040 |
Why?
|
Disease | 1 | 1999 | 90 | 0.040 |
Why?
|
Health Planning | 1 | 2018 | 17 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2020 | 456 | 0.040 |
Why?
|
Blood Platelets | 1 | 2019 | 149 | 0.040 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2019 | 47 | 0.040 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2001 | 275 | 0.040 |
Why?
|
Denmark | 1 | 1998 | 15 | 0.040 |
Why?
|
Risk | 1 | 2000 | 674 | 0.040 |
Why?
|
Teaching Materials | 2 | 2008 | 12 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2020 | 231 | 0.040 |
Why?
|
Frailty | 1 | 2019 | 58 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2022 | 669 | 0.040 |
Why?
|
Ethics, Medical | 1 | 2000 | 306 | 0.040 |
Why?
|
Decision Making, Organizational | 1 | 2016 | 6 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2019 | 240 | 0.040 |
Why?
|
Videotape Recording | 1 | 2017 | 47 | 0.040 |
Why?
|
Self Administration | 1 | 2017 | 73 | 0.040 |
Why?
|
Negotiating | 1 | 2016 | 19 | 0.040 |
Why?
|
Data Accuracy | 1 | 2016 | 31 | 0.040 |
Why?
|
Health Personnel | 1 | 2019 | 202 | 0.040 |
Why?
|
Prediabetic State | 1 | 2016 | 39 | 0.040 |
Why?
|
Cost Savings | 2 | 2011 | 66 | 0.040 |
Why?
|
Faculty, Medical | 2 | 2008 | 178 | 0.040 |
Why?
|
Self-Management | 1 | 2016 | 29 | 0.040 |
Why?
|
Social Perception | 1 | 2017 | 95 | 0.040 |
Why?
|
Anticoagulants | 1 | 2019 | 408 | 0.030 |
Why?
|
Support Vector Machine | 1 | 2016 | 25 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 90 | 0.030 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2016 | 24 | 0.030 |
Why?
|
Checklist | 1 | 2016 | 57 | 0.030 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2015 | 6 | 0.030 |
Why?
|
Problem Solving | 1 | 2015 | 54 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2001 | 1939 | 0.030 |
Why?
|
Vision Tests | 1 | 2015 | 20 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2015 | 153 | 0.030 |
Why?
|
Accelerometry | 1 | 2015 | 36 | 0.030 |
Why?
|
Equipment Design | 1 | 2016 | 406 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 2015 | 28 | 0.030 |
Why?
|
Dimensional Measurement Accuracy | 1 | 2014 | 4 | 0.030 |
Why?
|
Demography | 1 | 2015 | 177 | 0.030 |
Why?
|
Empathy | 1 | 2016 | 147 | 0.030 |
Why?
|
Information Systems | 1 | 2014 | 29 | 0.030 |
Why?
|
Polysomnography | 1 | 2014 | 151 | 0.030 |
Why?
|
Creatinine | 1 | 2015 | 338 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2014 | 131 | 0.030 |
Why?
|
Economics, Medical | 1 | 1993 | 6 | 0.030 |
Why?
|
Egypt | 1 | 2013 | 13 | 0.030 |
Why?
|
Feeding Behavior | 1 | 1996 | 324 | 0.030 |
Why?
|
Efficiency | 1 | 1993 | 40 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 860 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 859 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2013 | 54 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2014 | 117 | 0.030 |
Why?
|
Sick Leave | 1 | 2012 | 13 | 0.030 |
Why?
|
Military Medicine | 1 | 2012 | 20 | 0.030 |
Why?
|
Phenotype | 1 | 2019 | 2378 | 0.030 |
Why?
|
Patient Credit and Collection | 1 | 2012 | 2 | 0.030 |
Why?
|
Hemorrhoids | 1 | 1991 | 5 | 0.030 |
Why?
|
Sex Distribution | 1 | 2012 | 173 | 0.030 |
Why?
|
Anus Diseases | 1 | 1991 | 14 | 0.030 |
Why?
|
Rectal Diseases | 1 | 1991 | 24 | 0.030 |
Why?
|
Directive Counseling | 1 | 2012 | 34 | 0.030 |
Why?
|
Australia | 1 | 2011 | 99 | 0.030 |
Why?
|
Schools, Medical | 1 | 2012 | 123 | 0.030 |
Why?
|
Animals | 2 | 2022 | 26582 | 0.020 |
Why?
|
American Heart Association | 1 | 2011 | 92 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 677 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2011 | 136 | 0.020 |
Why?
|
Europe | 1 | 2011 | 309 | 0.020 |
Why?
|
Admitting Department, Hospital | 1 | 2010 | 1 | 0.020 |
Why?
|
Disease Progression | 1 | 2015 | 1531 | 0.020 |
Why?
|
Awards and Prizes | 1 | 2010 | 36 | 0.020 |
Why?
|
Klebsiella | 1 | 2009 | 6 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2010 | 40 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2010 | 57 | 0.020 |
Why?
|
Maryland | 1 | 2009 | 35 | 0.020 |
Why?
|
Pseudomonas | 1 | 2009 | 51 | 0.020 |
Why?
|
Enterococcus | 1 | 2009 | 35 | 0.020 |
Why?
|
Alleles | 1 | 2013 | 1128 | 0.020 |
Why?
|
Drug Information Services | 1 | 2008 | 1 | 0.020 |
Why?
|
Total Quality Management | 1 | 2009 | 34 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 819 | 0.020 |
Why?
|
Drug Utilization Review | 1 | 2008 | 14 | 0.020 |
Why?
|
Community Health Services | 1 | 2010 | 80 | 0.020 |
Why?
|
Developed Countries | 1 | 2008 | 24 | 0.020 |
Why?
|
Recurrence | 1 | 2011 | 1139 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2008 | 27 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2008 | 69 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2009 | 170 | 0.020 |
Why?
|
Health Promotion | 1 | 2010 | 160 | 0.020 |
Why?
|
Mice | 1 | 2022 | 11352 | 0.020 |
Why?
|
Models, Organizational | 1 | 2008 | 46 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2012 | 1805 | 0.020 |
Why?
|
Psychology, Educational | 1 | 2006 | 2 | 0.020 |
Why?
|
Electronic Mail | 1 | 2006 | 14 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 674 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2009 | 263 | 0.020 |
Why?
|
Escherichia coli | 1 | 2009 | 597 | 0.020 |
Why?
|
Intention | 1 | 2006 | 51 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 549 | 0.020 |
Why?
|
Stroke Volume | 1 | 2008 | 456 | 0.020 |
Why?
|
Models, Psychological | 1 | 2006 | 157 | 0.020 |
Why?
|
Medical Informatics | 1 | 2005 | 47 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2006 | 168 | 0.020 |
Why?
|
Canada | 1 | 2003 | 204 | 0.010 |
Why?
|
New England | 1 | 2001 | 10 | 0.010 |
Why?
|
Portugal | 1 | 2001 | 21 | 0.010 |
Why?
|
Organizational Policy | 1 | 2001 | 55 | 0.010 |
Why?
|
Job Description | 1 | 2000 | 8 | 0.010 |
Why?
|
Euthanasia, Passive | 1 | 2000 | 16 | 0.010 |
Why?
|
Medical Futility | 1 | 2000 | 28 | 0.010 |
Why?
|
Ethics, Clinical | 1 | 2000 | 48 | 0.010 |
Why?
|
Benchmarking | 1 | 2000 | 78 | 0.010 |
Why?
|
Choriocarcinoma | 1 | 1979 | 7 | 0.010 |
Why?
|
Hemoptysis | 1 | 1979 | 24 | 0.010 |
Why?
|
Sweden | 1 | 1997 | 40 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2003 | 2379 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2003 | 849 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1997 | 143 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 1979 | 227 | 0.010 |
Why?
|
Barium | 1 | 1991 | 31 | 0.010 |
Why?
|
Occult Blood | 1 | 1991 | 16 | 0.010 |
Why?
|
Outpatient Clinics, Hospital | 1 | 1991 | 23 | 0.010 |
Why?
|
Sigmoidoscopy | 1 | 1991 | 36 | 0.010 |
Why?
|
Enema | 1 | 1991 | 37 | 0.010 |
Why?
|
New York | 1 | 1991 | 69 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1991 | 156 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1979 | 2262 | 0.000 |
Why?
|
Radiography | 1 | 1979 | 813 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1979 | 1056 | 0.000 |
Why?
|
Pregnancy | 1 | 1979 | 2894 | 0.000 |
Why?
|